miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

Citations Over TimeTop 10% of 2014 papers

Abstract

This study supports the extracellular environment as an important source of minimally invasive predictive biomarkers representing their cellular origin. Using miR-34a as example, we showed that biomarkers identified in this manner may also hold functional relevance.

Related Papers

• → Regulated delivery of molecular cargo to invasive tumour-derived microvesicles(2015)176 cited
• → Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability(2012)97 cited
• → miR-200a targets Gelsolin: A novel mechanism regulating secretion of microvesicles in hepatocellular carcinoma cells(2017)28 cited
• → Inhibitory effect of microvesicles collected from stored blood on platelet aggregation(1981)5 cited
• → The bioactive content of CTCL cell line-derived exosomes and small microvesicles: First study in CTCL(2018)